ATE89739T1 - Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. - Google Patents

Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.

Info

Publication number
ATE89739T1
ATE89739T1 AT90113408T AT90113408T ATE89739T1 AT E89739 T1 ATE89739 T1 AT E89739T1 AT 90113408 T AT90113408 T AT 90113408T AT 90113408 T AT90113408 T AT 90113408T AT E89739 T1 ATE89739 T1 AT E89739T1
Authority
AT
Austria
Prior art keywords
inflammatory
composition containing
containing glutathione
allergic composition
glutathione derivatives
Prior art date
Application number
AT90113408T
Other languages
English (en)
Inventor
Shinji Ohmori
Kazumi Ogata
Takahiro Sakaue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE89739T1 publication Critical patent/ATE89739T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT90113408T 1989-07-14 1990-07-13 Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. ATE89739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1183484A JP2815179B2 (ja) 1989-07-14 1989-07-14 抗炎症および／または抗アレルギー剤
EP90113408A EP0408044B1 (de) 1989-07-14 1990-07-13 Entzündungshemmende und/oder antiallergische Zusammensetzung, die Glutathionderivate enthält

Publications (1)

Publication Number Publication Date
ATE89739T1 true ATE89739T1 (de) 1993-06-15

Family

ID=16136622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113408T ATE89739T1 (de) 1989-07-14 1990-07-13 Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.

Country Status (10)

Country Link
US (1) US5135952A (de)
EP (1) EP0408044B1 (de)
JP (1) JP2815179B2 (de)
KR (1) KR0145412B1 (de)
AT (1) ATE89739T1 (de)
CA (1) CA2020474C (de)
DE (1) DE69001722T2 (de)
DK (1) DK0408044T3 (de)
ES (1) ES2055235T3 (de)
RU (1) RU2050156C1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2919870B2 (ja) * 1989-09-29 1999-07-19 千寿製薬株式会社 肝障害抑制剤
CA2050929A1 (en) * 1990-02-17 1991-08-18 Shinji Ohmori Glutathione derivatives
DE69122831T2 (de) * 1990-04-26 1997-03-27 Senju Pharma Co S-(niedere fettsäuren)-substituierte glutathionderivate
US5212159A (en) * 1991-02-27 1993-05-18 Senju Pharmaceutical Co., Ltd. Anticataract composition
CA2099346A1 (en) * 1992-07-17 1994-01-18 Shinji Ohmori Lipid metabolism improving composition
CA2213266A1 (en) * 1996-09-04 1998-03-04 Hideki Tsuruoka Method for isolation and purification of s-(1,2-dicarboxyethyl) glutathione
KR20030035328A (ko) * 2001-10-31 2003-05-09 삼성전자주식회사 공기조화기의 실외기
KR100643690B1 (ko) * 2004-03-17 2006-11-10 삼성전자주식회사 공기조화기
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
JP2013035772A (ja) * 2011-08-05 2013-02-21 Osaka City Univ 白血球活性化抑制剤
US9744192B2 (en) * 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis
RU2604413C1 (ru) * 2015-06-17 2016-12-10 Марина Николаевна Вольгова Способ лечения хронического аллергического наружного отита
US20180008665A1 (en) * 2016-07-05 2018-01-11 CanTrust LifeScience Corp. Methods of treating and preventing gout and lead nephropathy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788945A (de) * 1971-09-20 1973-03-19 Oreal
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
US4755535A (en) * 1986-04-23 1988-07-05 Nelson Research & Development Co. Compositions comprising 1-substituted azacycloalkenes
JPS638337A (ja) * 1986-06-30 1988-01-14 Senjiyu Seiyaku Kk 抗血液凝固剤
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
ES2037230T3 (es) * 1987-08-28 1993-06-16 Eli Lilly And Company Composiciones activadoras de la penetracion.
JPS6479956A (en) * 1987-09-21 1989-03-24 Mitsubishi Electric Corp Magnetic recording and reproducing device

Also Published As

Publication number Publication date
RU2050156C1 (ru) 1995-12-20
EP0408044B1 (de) 1993-05-26
DE69001722D1 (de) 1993-07-01
EP0408044A3 (en) 1991-07-17
DE69001722T2 (de) 1993-09-23
DK0408044T3 (da) 1993-06-21
US5135952A (en) 1992-08-04
EP0408044A2 (de) 1991-01-16
JPH0348626A (ja) 1991-03-01
KR0145412B1 (ko) 1998-07-15
KR910002437A (ko) 1991-02-25
CA2020474A1 (en) 1991-01-15
CA2020474C (en) 1998-09-29
JP2815179B2 (ja) 1998-10-27
ES2055235T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
EP1035123A4 (de) Neue heterozyklische verbindungen
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
DK0420121T3 (da) Antitumormiddel
PT90034A (pt) Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas
EP0546177A4 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
DK0420224T3 (da) Anthihepatopatisk middel
DK0654473T3 (da) Cyclopropanderivater og antivirale midler med indhold deraf
FI895139A0 (fi) Pyrrolidinderivat.
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
AU2013888A (en) Uricosuric composition
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE67197T1 (de) Thiadiazinon-derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee